Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
|Articles|June 12, 2002
Alliance Imaging top exec resigns
Jamie E. Hopping, president and COO of Alliance Imaging, will resign effective June 30. Hopping, who joined Alliance Imaging in November 2000, will become COO of Nashville-based Ardent Healthcare, a provider of healthcare services. He will also serve on
Advertisement
Jamie E. Hopping, president and COO of Alliance Imaging, will resign effective June 30. Hopping, who joined Alliance Imaging in November 2000, will become COO of Nashville-based Ardent Healthcare, a provider of healthcare services. He will also serve on Ardent's board of directors. Alliance, a provider of outsourced diagnostic imaging services, has begun the search process for a new COO. In the interim, the company's executive vice presidents for the eastern and western U.S. will report to Richard N. Zehner, Alliance chair and CEO.
Advertisement
Related to this article
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
For patients with localized prostate cancer, stereotactic body radiotherapy (SBRT) offered comparable freedom from biochemical/clinical failure at eight years and nearly 40 percent lower urinary incontinence in comparison to radical prostatectomy, according to research presented at the ASTRO conference.
Catch up on the most well-viewed video interviews from Diagnostic Imaging in September 2026.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
2
Radiology and Building the Alzheimer’s Care Pathway of the Future
3
MRI, CT or Ultrasound: Which Modality Offers the Most Utility for Imaging of Pancreatic Cancer?
4
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1
5